NSI-189 is a nootropic and neurogenic research chemical derived from nicotinamide and pyrazine created by Neuralstem Inc. Research into NSI-189 has been heavily funded by the Defense Advanced Research Projects Agency (DARPA) and the National Institutes of Health (NIH).
This page contains content from the copyrighted Wikipedia article "NSI-189"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
